However, high cost of surgical procedures and high rate of complications are some of the major
factors restraining growth of the global urethral stricture treatment market. According to
Healthcare Cost and Utilization Project (HCUP) 2016, the average cost of male urethroplasty can
range between US$ 5,677–US$ 10,000 with an average increase of US$ 616 per year in the U.S.
Urethral Stricture Treatment Market – Regional Insights
On the basis of geography, the global urethral stricture treatment market is segmented into
North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America
held dominant position in the global urethral stricture treatment market in 2017. This is owing
to rising number of urethroplasties for urethral strictures in the region. Moreover, high adoption
rate of innovative technologies and numerous product development is driving growth of the
market. For instance, in February 2018, Urotronic, an early stage medical device company,
received license for its product, Optilume drug-coated balloon (DCB), which will be used to
treat urethral strictures in Canada. The development of this drug-coated ballon have a
significant impact across Canada due to scarcity of physicians currently to perform majority of
urethral stricture treatments.
Asia Pacific is expected to witness significant growth in the urethral stricture treatment market
during the forecast period, owing to improving health care infrastructure in economies such as
India and China, and increasing demand for efficient treatment options for urethral strictures.
Urethral Stricture Treatment Market – Competitive Landscape
Major players operating in the global urethral stricture treatment market include C. R. Bard,
Inc., Amecath, Uromed, MedNova, Allium Medical, Surgimedik, Cook Medical Inc., Mednova,
Taewoong Medical, Teleflex Incorporated, B. Braun Holding GmbH & Co. KG, Urotech,
Coloplast Ltd, Boston Scientific Corporation, and Pnn Medical A/S. Key players are focusing on
expanding their product portfolio, in order to retain dominant position in the market. For
instance, Allium Medical, which manufactures and markets minimally invasive products, entered
into the market with its product, Allium’s Ureteral Stents, which has some unique composition
and better bio-compatibility.
Browse Complete Report For More Information @ http://bit.ly/2IOM4FA
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-
ready syndicated research reports, custom market analysis, consulting services, and competitive